CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bangkok Lab and Cosmetic PCL is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bangkok Lab and Cosmetic PCL
48/1 Moo 5 Nongshaesao Rd.
Namphu, Mueang Ratchaburi
Phone: +66 32719900p:+66 32719900 RATCHABURI, 70000  Thailand Ticker: BLCBLC
Business Summary
Bangkok Lab and Cosmetic Public Company Limited is a Thailand-based producer and researcher of health products. The principal activities of the Company and subsidiaries are engaged in the manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals. It operates through pharmaceuticals and medicinal chemical products segment. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, Calza-750 TAB FC, and others. Its subsidiaries include Bangkok Drug Co., Ltd., and Pharma Alliance Co., Ltd.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations
3841 Surgical and medical instruments and apparatus
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Executive Committee, Executive Director SuvitNgamphupan
Independent Chairman of the Board of Directors WanchaiSuttanan
Chief Financial Officer, Executive Director, Member of the Executive Committee SomchaiPispahutarn 1/1/2023
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 698 (As of 12/31/2023)
Outstanding Shares: 600,000,000 (As of 9/30/2024)
Stock Exchange: BAK
Fax Number: +66 32719917


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024